[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-001", "question": "A 48-year-old woman with a history of systemic lupus erythematosus (SLE) on hydroxychloroquine and low-dose prednisone presents with 3 weeks of progressive dyspnea on exertion and dry cough. High-resolution CT shows diffuse ground-glass opacities with superimposed fine reticulation and subpleural sparing. Bronchoalveolar lavage reveals lymphocytic predominance (65%) with CD4:CD8 ratio of 0.8. Pulmonary function tests show a restrictive pattern with severely reduced DLCO (38% predicted). Which of the following is the most appropriate next step in management?", "options": ["Initiate high-dose intravenous methylprednisolone followed by oral prednisone 1 mg/kg/day", "Add mycophenolate mofetil to current immunosuppression", "Discontinue hydroxychloroquine and observe for 4 weeks", "Perform surgical lung biopsy to confirm usual interstitial pneumonia pattern", "Start rituximab therapy without additional testing"], "answer": "B", "answer_index": 1, "explanation": "The presentation is classic for lymphocytic interstitial pneumonia (LIP) associated with SLE, characterized by ground-glass opacities with reticulation, lymphocytic BAL, and low CD4:CD8 ratio. LIP in connective tissue disease typically requires more aggressive immunosuppression beyond steroids alone. Mycophenolate mofetil is the preferred steroid-sparing agent for SLE-associated interstitial lung disease with this pattern. High-dose steroids alone (A) are insufficient for progressive LIP. Hydroxychloroquine cessation (C) is unlikely to reverse established ILD. Surgical biopsy (D) is unnecessary with characteristic HRCT and BAL findings. Rituximab (E) is reserved for refractory cases after conventional immunosuppression fails.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a patient with SLE presenting with progressive ILD showing ground-glass opacities, lymphocytic BAL with inverted CD4:CD8 ratio, and severely reduced DLCO. The author frames this as lymphocytic interstitial pneumonia (LIP) requiring mycophenolate addition. However, critical details are missing: (1) current prednisone dose is stated as 'low-dose' but not quantified—if already on adequate steroids, adding mycophenolate makes sense; if on minimal steroids (e.g., 5mg/day), pulse steroids may be needed first; (2) disease activity markers and acuity are unclear—'progressive over 3 weeks' with severely reduced DLCO (38%) suggests aggressive disease that might warrant pulse steroids initially; (3) no mention of excluding infection or drug toxicity systematically. Both options A (high-dose steroids) and B (add mycophenolate) are defensible depending on unstated assumptions about current steroid adequacy and disease severity. The distinction between 'pulse steroids first' versus 'add steroid-sparing agent to current regimen' requires knowing baseline steroid dose and whether this represents acute deterioration versus subacute progression on inadequate therapy. Medical accuracy: The pathophysiology and treatment principles are sound, but the clinical scenario lacks specificity to definitively choose between escalating steroids versus adding a second agent. Minimal fix: Specify current prednisone dose (e.g., '5 mg daily') and clarify whether this represents acute-on-chronic or new-onset ILD to justify mycophenolate addition over steroid pulse.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a patient with SLE presenting with progressive ILD showing ground-glass opacities, lymphocytic BAL with inverted CD4:CD8 ratio, and severely reduced DLCO. The author frames this as lymphocytic interstitial pneumonia (LIP) requiring mycophenolate addition. However, critical details are missing: (1) current prednisone dose is stated as 'low-dose' but not quantified—if already on adequate steroids, adding mycophenolate makes sense; if on minimal steroids (e.g., 5mg/day), pulse steroids may be needed first; (2) disease activity markers and acuity are unclear—'progressive over 3 weeks' with severely reduced DLCO (38%) suggests aggressive disease that might warrant pulse steroids initially; (3) no mention of excluding infection or drug toxicity systematically. Both options A (high-dose steroids) and B (add mycophenolate) are defensible depending on unstated assumptions about current steroid adequacy and disease severity. The distinction between 'pulse steroids first' versus 'add steroid-sparing agent to current regimen' requires knowing baseline steroid dose and whether this represents acute deterioration versus subacute progression on inadequate therapy. Medical accuracy: The pathophysiology and treatment principles are sound, but the clinical scenario lacks specificity to definitively choose between escalating steroids versus adding a second agent. Minimal fix: Specify current prednisone dose (e.g., '5 mg daily') and clarify whether this represents acute-on-chronic or new-onset ILD to justify mycophenolate addition over steroid pulse.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-002", "question": "A 62-year-old man with metastatic renal cell carcinoma on nivolumab and ipilimumab presents with acute-onset diplopia, ptosis, and dysphagia 6 weeks after initiation. Neurological exam reveals bilateral asymmetric ophthalmoparesis, fatigable ptosis, proximal muscle weakness, and normal pupillary responses. Repetitive nerve stimulation shows 25% decrement at 3Hz. Which of the following is the most specific diagnostic test to confirm the underlying pathophysiology?", "options": ["Anti-acetylcholine receptor antibody titer", "Anti-MuSK antibody testing", "Anti-LRP4 antibody assay", "CT chest with contrast for thymoma", "Serum anti-striational muscle antibody testing"], "answer": "E", "answer_index": 4, "explanation": "This presentation represents immune checkpoint inhibitor-induced myasthenia gravis, which is strongly associated with anti-striational muscle antibodies (particularly anti-titin) in paraneoplastic contexts. While anti-AChR antibodies (A) are positive in most generalized MG, anti-striational antibodies have higher specificity for thymoma-associated and paraneoplastic MG in cancer patients on immunotherapy. Anti-MuSK (B) and anti-LRP4 (C) antibodies are associated with different MG subtypes but not specifically with paraneoplastic forms. CT for thymoma (D) is indicated but not the most specific test for pathophysiology. The combination of immune checkpoint therapy with these neurological findings makes anti-striational antibodies the key diagnostic marker.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict: Miskeyed - anti-AChR antibody is the correct answer. Key stem clues: 62-year-old on checkpoint inhibitors (nivolumab/ipilimumab) presenting with classic myasthenia gravis features (fatigable ptosis, ophthalmoparesis, proximal weakness, normal pupils, 25% decrement on RNS). The question asks for the \\\"most specific diagnostic test to confirm the underlying pathophysiology\\\" of myasthenia gravis. Main logical issue: Anti-AChR antibodies (A) are 80-90% sensitive and highly specific for MG pathophysiology (antibody-mediated neuromuscular junction dysfunction). Anti-striational antibodies (E, the keyed answer) are markers of thymoma association, not pathophysiology confirmatory tests - they don't confirm the neuromuscular junction dysfunction mechanism. The rationale conflates \\\"associated with paraneoplastic context\\\" with \\\"confirms pathophysiology.\\\" Anti-striational antibodies indicate thymoma risk but don't establish the acetylcholine receptor blockade mechanism that defines MG. Medical accuracy issue: The explanation incorrectly prioritizes an association marker over the pathophysiologic diagnostic test. Minimal fix: Change the key to A (anti-AChR antibody), or reword the question to ask \\\"which test best identifies thymoma-associated risk\\\" to justify answer E.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - anti-AChR antibody is the correct answer. Key stem clues: 62-year-old on checkpoint inhibitors (nivolumab/ipilimumab) presenting with classic myasthenia gravis features (fatigable ptosis, ophthalmoparesis, proximal weakness, normal pupils, 25% decrement on RNS). The question asks for the \"most specific diagnostic test to confirm the underlying pathophysiology\" of myasthenia gravis. Main logical issue: Anti-AChR antibodies (A) are 80-90% sensitive and highly specific for MG pathophysiology (antibody-mediated neuromuscular junction dysfunction). Anti-striational antibodies (E, the keyed answer) are markers of thymoma association, not pathophysiology confirmatory tests - they don't confirm the neuromuscular junction dysfunction mechanism. The rationale conflates \"associated with paraneoplastic context\" with \"confirms pathophysiology.\" Anti-striational antibodies indicate thymoma risk but don't establish the acetylcholine receptor blockade mechanism that defines MG. Medical accuracy issue: The explanation incorrectly prioritizes an association marker over the pathophysiologic diagnostic test. Minimal fix: Change the key to A (anti-AChR antibody), or reword the question to ask \"which test best identifies thymoma-associated risk\" to justify answer E.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-003", "question": "A 34-year-old pregnant woman at 32 weeks gestation presents with acute-onset severe headache, photophobia, and confusion. BP is 150/95 mmHg. MRI brain shows bilateral cortical and subcortical edema predominantly in posterior parietal and occipital lobes, with patchy cortical diffusion restriction. MR venography is normal. She has no proteinuria. Which of the following is the most likely underlying vascular pathophysiology?", "options": ["Cerebral venous sinus thrombosis", "Posterior reversible encephalopathy syndrome", "Reversible cerebral vasoconstriction syndrome", "Eclampsia without hypertension", "Posterior circulation ischemic stroke"], "answer": "C", "answer_index": 2, "explanation": "This represents reversible cerebral vasoconstriction syndrome (RCVS) in pregnancy, characterized by thunderclap headache, normal venography, and posterior-predominant edema with diffusion restriction. The key distinction from PRES (B) is the presence of cortical diffusion restriction and more severe headache. RCVS involves segmental cerebral arterial vasoconstriction rather than hypertensive breakthrough autoregulation. Cerebral venous thrombosis (A) would show venous occlusion. Eclampsia (D) typically requires significant hypertension and proteinuria. Posterior circulation stroke (E) would show more defined arterial territory infarction rather than patchy cortical involvement.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer (C, RCVS) is incorrect; the best answer is B (PRES). Key stem clues: 32-week pregnant woman with acute severe headache, BP 150/95 mmHg, confusion, bilateral posterior-predominant cortical/subcortical edema on MRI, normal MR venography, no proteinuria. The clinical presentation and imaging findings are classic for PRES (posterior reversible encephalopathy syndrome): pregnancy as risk factor, moderately elevated BP, posterior-predominant vasogenic edema, and acute neurologic symptoms. The rationale incorrectly claims cortical diffusion restriction distinguishes RCVS from PRES, but patchy cortical DWI restriction can occur in PRES (cytotoxic edema in severe cases) and does not exclude it. RCVS typically presents with thunderclap headache and requires demonstration of arterial vasoconstriction on vessel imaging (CTA/MRA), which is not mentioned here. Normal MR venography excludes option A. Option D is nonsensical (eclampsia by definition requires seizures and typically significant hypertension). Option E doesn't fit the bilateral posterior distribution. Medical accuracy issue: The rationale mischaracterizes the imaging distinction between PRES and RCVS. Minimal fix: Change key to B, or add explicit vessel imaging showing segmental vasoconstriction to support C.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer (C, RCVS) is incorrect; the best answer is B (PRES). Key stem clues: 32-week pregnant woman with acute severe headache, BP 150/95 mmHg, confusion, bilateral posterior-predominant cortical/subcortical edema on MRI, normal MR venography, no proteinuria. The clinical presentation and imaging findings are classic for PRES (posterior reversible encephalopathy syndrome): pregnancy as risk factor, moderately elevated BP, posterior-predominant vasogenic edema, and acute neurologic symptoms. The rationale incorrectly claims cortical diffusion restriction distinguishes RCVS from PRES, but patchy cortical DWI restriction can occur in PRES (cytotoxic edema in severe cases) and does not exclude it. RCVS typically presents with thunderclap headache and requires demonstration of arterial vasoconstriction on vessel imaging (CTA/MRA), which is not mentioned here. Normal MR venography excludes option A. Option D is nonsensical (eclampsia by definition requires seizures and typically significant hypertension). Option E doesn't fit the bilateral posterior distribution. Medical accuracy issue: The rationale mischaracterizes the imaging distinction between PRES and RCVS. Minimal fix: Change key to B, or add explicit vessel imaging showing segmental vasoconstriction to support C.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-004", "question": "A 57-year-old man with alcoholic cirrhosis (Child-Pugh B) presents with fever, abdominal pain, and altered mental status. Paracentesis reveals ascitic fluid with 450 neutrophils/mm³. Blood and ascitic fluid cultures grow extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. He receives meropenem for 72 hours but remains febrile with worsening encephalopathy. Repeat paracentesis shows 520 neutrophils/mm³ with negative cultures. Which of the following is the most appropriate next step?", "options": ["Add intravenous vancomycin for possible MRSA coverage", "Switch to piperacillin-tazobactam given ESBL resistance patterns", "Perform urgent transjugular intrahepatic portosystemic shunt placement", "Administer intravenous albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3", "Add intravenous metronidazole for anaerobic coverage"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes recurrent or persistent spontaneous bacterial peritonitis (SBP) with treatment failure, which in the context of cirrhosis carries high mortality. TIPS placement reduces portal pressure and may improve outcomes in refractory SBP by decreasing bacterial translocation. Albumin (D) is indicated for SBP but already should have been given initially. Antibiotic changes (A, B, E) are inappropriate with negative repeat cultures and clinical deterioration despite appropriate initial therapy. In refractory SBP with ongoing inflammation despite adequate antibiotics, TIPS can be life-saving by addressing the underlying pathophysiology of portal hypertension.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: ESBL E. coli SBP treated with appropriate antibiotic (meropenem) for 72 hours, persistent fever and worsening encephalopathy, repeat paracentesis shows persistent neutrophilia (520/mm³) but negative cultures. The question asks for the most appropriate NEXT step. Main logical issue: The keyed answer (C, TIPS) is not standard management for treatment-failure SBP. TIPS is indicated for refractory ascites, not for acute SBP treatment failure. The correct answer should be D (albumin). The stem explicitly states the patient has worsening encephalopathy and persistent inflammation despite appropriate antibiotics. Albumin administration (1.5 g/kg day 1, 1.0 g/kg day 3) is standard of care for SBP to prevent hepatorenal syndrome and reduce mortality - this should be given if not already administered. The rationale's claim that \\\"albumin should have been given initially\\\" actually supports D as the answer, since the stem never states albumin was given. Main medical accuracy issue: TIPS for acute SBP treatment failure is not evidence-based or guideline-recommended. TIPS is used for refractory ascites or variceal bleeding, not acute infection management. Minimal fix: Change the correct answer key from C to D, or add explicit statement that albumin was already administered and describe true refractory ascites requiring TIPS.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: ESBL E. coli SBP treated with appropriate antibiotic (meropenem) for 72 hours, persistent fever and worsening encephalopathy, repeat paracentesis shows persistent neutrophilia (520/mm³) but negative cultures. The question asks for the most appropriate NEXT step. Main logical issue: The keyed answer (C, TIPS) is not standard management for treatment-failure SBP. TIPS is indicated for refractory ascites, not for acute SBP treatment failure. The correct answer should be D (albumin). The stem explicitly states the patient has worsening encephalopathy and persistent inflammation despite appropriate antibiotics. Albumin administration (1.5 g/kg day 1, 1.0 g/kg day 3) is standard of care for SBP to prevent hepatorenal syndrome and reduce mortality - this should be given if not already administered. The rationale's claim that \"albumin should have been given initially\" actually supports D as the answer, since the stem never states albumin was given. Main medical accuracy issue: TIPS for acute SBP treatment failure is not evidence-based or guideline-recommended. TIPS is used for refractory ascites or variceal bleeding, not acute infection management. Minimal fix: Change the correct answer key from C to D, or add explicit statement that albumin was already administered and describe true refractory ascites requiring TIPS.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-005", "question": "A 41-year-old woman with antiphospholipid syndrome (triple positive) on warfarin (INR 2.8) presents with acute right hemiparesis and aphasia. CT angiogram shows complete occlusion of the left middle cerebral artery M1 segment. She is 4 hours from symptom onset. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator", "Proceed with mechanical thrombectomy without thrombolysis", "Give intravenous heparin bolus followed by infusion", "Administer intra-arterial thrombolysis via catheter", "Continue warfarin and add aspirin 325 mg"], "answer": "B", "answer_index": 1, "explanation": "In antiphospholipid syndrome with acute large vessel occlusion, mechanical thrombectomy is indicated regardless of anticoagulation status. tPA (A) is contraindicated with therapeutic INR >1.7. Heparin (C) adds bleeding risk without proven benefit in acute stroke with therapeutic anticoagulation. Intra-arterial thrombolysis (D) carries similar bleeding risks as IV tPA. Continuing warfarin with aspirin (E) does not address acute occlusion. Mechanical thrombectomy has shown benefit up to 24 hours in selected patients and is not contraindicated by therapeutic anticoagulation if the procedure can be performed safely.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 41-year-old woman with antiphospholipid syndrome on therapeutic warfarin (INR 2.8) presenting with acute ischemic stroke from left MCA M1 occlusion within 4 hours. Key discriminating findings: (1) large vessel occlusion (LVO) confirmed on CTA, (2) therapeutic anticoagulation with INR 2.8, (3) within thrombectomy time window. The keyed answer (B, mechanical thrombectomy without thrombolysis) is defensible because: IV tPA is contraindicated with INR >1.7 per guidelines; mechanical thrombectomy remains indicated for LVO strokes regardless of anticoagulation status and has proven benefit up to 24 hours in selected patients. Alternative assessment: (A) contraindicated due to elevated INR and bleeding risk; (C) heparin adds no benefit and increases hemorrhage risk in acute stroke with therapeutic anticoagulation; (D) intra-arterial thrombolysis carries similar bleeding contraindications as IV tPA with therapeutic INR; (E) fails to address acute occlusion requiring urgent reperfusion. Medical accuracy: Consistent with current AHA/ASA guidelines and major thrombectomy trials. No logical flaws identified. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 41-year-old woman with antiphospholipid syndrome on therapeutic warfarin (INR 2.8) presenting with acute ischemic stroke from left MCA M1 occlusion within 4 hours. Key discriminating findings: (1) large vessel occlusion (LVO) confirmed on CTA, (2) therapeutic anticoagulation with INR 2.8, (3) within thrombectomy time window. The keyed answer (B, mechanical thrombectomy without thrombolysis) is defensible because: IV tPA is contraindicated with INR >1.7 per guidelines; mechanical thrombectomy remains indicated for LVO strokes regardless of anticoagulation status and has proven benefit up to 24 hours in selected patients. Alternative assessment: (A) contraindicated due to elevated INR and bleeding risk; (C) heparin adds no benefit and increases hemorrhage risk in acute stroke with therapeutic anticoagulation; (D) intra-arterial thrombolysis carries similar bleeding contraindications as IV tPA with therapeutic INR; (E) fails to address acute occlusion requiring urgent reperfusion. Medical accuracy: Consistent with current AHA/ASA guidelines and major thrombectomy trials. No logical flaws identified. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-006", "question": "A 29-year-old woman presents with 6 months of progressive dyspnea and palpitations. Echocardiogram shows severe pulmonary hypertension (RVSP 85 mmHg) with right ventricular dilation but normal left heart function. Right heart catheterization confirms pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg). High-resolution CT shows mosaic attenuation and enlarged central pulmonary arteries. Ventilation-perfusion scan reveals multiple segmental perfusion defects. Which of the following is the definitive diagnostic test?", "options": ["Pulmonary angiogram", "CT pulmonary angiogram", "Genetic testing for BMPR2 mutation", "Lung biopsy", "Exercise right heart catheterization"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for chronic thromboembolic pulmonary hypertension (CTEPH). While V/Q scan is the screening test, pulmonary angiography remains the gold standard for defining surgical accessibility and planning pulmonary endarterectomy. CT pulmonary angiography (B) provides anatomical detail but has lower sensitivity for chronic thromboembolic material. Genetic testing (C) is for heritable pulmonary arterial hypertension, not CTEPH. Lung biopsy (D) is contraindicated in severe pulmonary hypertension. Exercise catheterization (E) may confirm exercise-induced PH but doesn't diagnose CTEPH. Pulmonary angiography is essential for determining operability in CTEPH.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a young woman with pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg), mosaic attenuation on HRCT, and multiple segmental perfusion defects on V/Q scan—classic findings for chronic thromboembolic pulmonary hypertension (CTEPH). The question asks for the \\\"definitive diagnostic test.\\\" Key discriminating findings: V/Q scan showing segmental perfusion defects strongly suggests CTEPH over other forms of pulmonary hypertension. Keyed answer (A, pulmonary angiogram) is correct because conventional pulmonary angiography remains the gold standard for CTEPH diagnosis, specifically for defining thrombus location, assessing surgical accessibility, and planning pulmonary endarterectomy. Alternative assessments: (B) CTPA provides anatomical detail but has lower sensitivity for chronic organized thrombi; (C) BMPR2 testing is for heritable PAH, not CTEPH; (D) lung biopsy is contraindicated in severe PH due to bleeding risk; (E) exercise catheterization doesn't diagnose CTEPH etiology. The item is medically accurate—pulmonary angiography is indeed the definitive test for surgical planning in CTEPH per current guidelines. No logical flaws; stem provides sufficient discriminating information. Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a young woman with pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg), mosaic attenuation on HRCT, and multiple segmental perfusion defects on V/Q scan—classic findings for chronic thromboembolic pulmonary hypertension (CTEPH). The question asks for the \"definitive diagnostic test.\" Key discriminating findings: V/Q scan showing segmental perfusion defects strongly suggests CTEPH over other forms of pulmonary hypertension. Keyed answer (A, pulmonary angiogram) is correct because conventional pulmonary angiography remains the gold standard for CTEPH diagnosis, specifically for defining thrombus location, assessing surgical accessibility, and planning pulmonary endarterectomy. Alternative assessments: (B) CTPA provides anatomical detail but has lower sensitivity for chronic organized thrombi; (C) BMPR2 testing is for heritable PAH, not CTEPH; (D) lung biopsy is contraindicated in severe PH due to bleeding risk; (E) exercise catheterization doesn't diagnose CTEPH etiology. The item is medically accurate—pulmonary angiography is indeed the definitive test for surgical planning in CTEPH per current guidelines. No logical flaws; stem provides sufficient discriminating information. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-007", "question": "A 63-year-old man with diabetes and peripheral arterial disease presents with 2 hours of acute, painless monocular vision loss in the right eye. Visual acuity is hand motion only. Funduscopy reveals a pale retina with cherry-red spot and boxcarring of retinal vessels. Carotid duplex shows 90% stenosis of the right internal carotid artery. Which of the following is the most urgent intervention?", "options": ["Intravenous tissue plasminogen activator", "Anterior chamber paracentesis", "Immediate carotid endarterectomy", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization"], "answer": "E", "answer_index": 4, "explanation": "This describes central retinal artery occlusion (CRAO) with cherry-red spot and boxcarring, indicating acute ischemia. Intra-arterial thrombolysis via selective ophthalmic artery catheterization within 6-12 hours may restore vision in CRAO, though evidence is limited. IV tPA (A) is not standard for CRAO. Anterior chamber paracentesis (B) is historical but ineffective. Carotid endarterectomy (C) addresses the source but not the acute occlusion. Hyperbaric oxygen (D) has limited evidence. Given the time window and severity, selective intra-arterial thrombolysis offers the best chance for visual recovery in this acute setting.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - option B is the most defensible immediate intervention. The vignette describes classic central retinal artery occlusion (CRAO) with cherry-red spot and boxcarring within 2 hours of onset. Key discriminating findings: acute painless monocular vision loss, hand-motion-only acuity, pale retina with cherry-red spot, boxcarring vessels, 2-hour window. The keyed answer (E: intra-arterial thrombolysis) is not standard care for CRAO and lacks robust evidence; it is rarely available emergently and requires specialized interventional capabilities not universally accessible. Option B (anterior chamber paracentesis) combined with ocular massage represents the traditional emergency intervention to dislodge emboli and restore flow, though evidence for efficacy is limited. While the rationale dismisses paracentesis as \\\"historical but ineffective,\\\" it remains more widely recommended as an immediate bedside intervention than intra-arterial thrombolysis, which is experimental and logistically impractical in most settings. The medical accuracy issue is that E overstates the role of a procedure with very limited evidence and availability. Minimal fix: Change key to B, or reframe question to ask about \\\"experimental interventions\\\" rather than \\\"most urgent intervention\\\" to justify E.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - option B is the most defensible immediate intervention. The vignette describes classic central retinal artery occlusion (CRAO) with cherry-red spot and boxcarring within 2 hours of onset. Key discriminating findings: acute painless monocular vision loss, hand-motion-only acuity, pale retina with cherry-red spot, boxcarring vessels, 2-hour window. The keyed answer (E: intra-arterial thrombolysis) is not standard care for CRAO and lacks robust evidence; it is rarely available emergently and requires specialized interventional capabilities not universally accessible. Option B (anterior chamber paracentesis) combined with ocular massage represents the traditional emergency intervention to dislodge emboli and restore flow, though evidence for efficacy is limited. While the rationale dismisses paracentesis as \"historical but ineffective,\" it remains more widely recommended as an immediate bedside intervention than intra-arterial thrombolysis, which is experimental and logistically impractical in most settings. The medical accuracy issue is that E overstates the role of a procedure with very limited evidence and availability. Minimal fix: Change key to B, or reframe question to ask about \"experimental interventions\" rather than \"most urgent intervention\" to justify E.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-008", "question": "A 38-year-old woman with history of mitral valve prolapse presents with 3 weeks of daily fevers, night sweats, and new-onset diastolic murmur. Blood cultures are negative after 72 hours. Transthoracic echocardiogram shows a 12mm mobile vegetation on the anterior mitral leaflet with severe mitral regurgitation. Which of the following organisms is most likely responsible?", "options": ["Streptococcus gallolyticus", "Coxiella burnetii", "Bartonella henselae", "Tropheryma whipplei", "Abiotrophia defectiva"], "answer": "C", "answer_index": 2, "explanation": "This presentation suggests culture-negative endocarditis in a patient with pre-existing mitral valve disease. Bartonella henselae is the most common cause of culture-negative endocarditis in patients with valve abnormalities, particularly associated with negative blood cultures, subacute presentation, and large vegetations. Coxiella burnetii (B) typically causes Q fever endocarditis with exposure history. Streptococcus gallolyticus (A) is culture-positive and associated with colorectal pathology. Tropheryma whipplei (D) causes Whipple's disease with systemic symptoms. Abiotrophia (E) is nutritionally variant but usually culture-positive. Bartonella requires serology or PCR for diagnosis and responds to specific antibiotic regimens.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes culture-negative endocarditis (blood cultures negative at 72 hours) with large vegetation in a patient with mitral valve prolapse. Key discriminating findings: negative blood cultures, subacute presentation (3 weeks), large 12mm vegetation, pre-existing valve disease. The keyed answer (Bartonella henselae, C) is defensible as a common cause of culture-negative endocarditis. However, Coxiella burnetii (B) is equally defensible—it is the most common cause of culture-negative endocarditis overall and classically presents with negative routine blood cultures, large vegetations, and pre-existing valve disease. The stem lacks critical discriminating details: no cat/flea exposure history (favoring Bartonella), no farm/animal exposure or chronic Q fever risk factors (favoring Coxiella), and 72-hour culture negativity is insufficient (some fastidious organisms may grow with extended incubation). Without exposure history or epidemiologic clues, both B and C are near-equally defensible. Medical accuracy: Both organisms are medically accurate causes of culture-negative endocarditis; the teaching point is sound but the stem is underspecified. Minimal fix: Add exposure history (e.g., 'recent cat scratch' for Bartonella or 'works on dairy farm' for Coxiella) to discriminate uniquely.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes culture-negative endocarditis (blood cultures negative at 72 hours) with large vegetation in a patient with mitral valve prolapse. Key discriminating findings: negative blood cultures, subacute presentation (3 weeks), large 12mm vegetation, pre-existing valve disease. The keyed answer (Bartonella henselae, C) is defensible as a common cause of culture-negative endocarditis. However, Coxiella burnetii (B) is equally defensible—it is the most common cause of culture-negative endocarditis overall and classically presents with negative routine blood cultures, large vegetations, and pre-existing valve disease. The stem lacks critical discriminating details: no cat/flea exposure history (favoring Bartonella), no farm/animal exposure or chronic Q fever risk factors (favoring Coxiella), and 72-hour culture negativity is insufficient (some fastidious organisms may grow with extended incubation). Without exposure history or epidemiologic clues, both B and C are near-equally defensible. Medical accuracy: Both organisms are medically accurate causes of culture-negative endocarditis; the teaching point is sound but the stem is underspecified. Minimal fix: Add exposure history (e.g., 'recent cat scratch' for Bartonella or 'works on dairy farm' for Coxiella) to discriminate uniquely.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-009", "question": "A 52-year-old woman with rheumatoid arthritis on methotrexate presents with progressive dyspnea and dry cough. High-resolution CT shows extensive ground-glass opacities with centrilobular nodules and tree-in-bud pattern predominantly in upper lobes. Bronchoscopy with transbronchial biopsy reveals non-necrotizing granulomas with multinucleated giant cells. Which of the following is the most likely diagnosis?", "options": ["Methotrexate pneumonitis", "Rheumatoid arthritis-associated interstitial lung disease", "Mycobacterium avium complex infection", "Sarcoidosis", "Hypersensitivity pneumonitis"], "answer": "C", "answer_index": 2, "explanation": "The combination of upper lobe predominance, tree-in-bud pattern, and non-necrotizing granulomas in an immunocompromised patient on methotrexate is classic for nontuberculous mycobacterial infection, particularly MAC. Methotrexate pneumonitis (A) typically shows diffuse alveolar damage pattern. RA-ILD (B) usually shows UIP or NSIP patterns. Sarcoidosis (D) shows perilymphatic nodules and hilar adenopathy. Hypersensitivity pneumonitis (E) shows centrilobular nodules but usually without tree-in-bud or upper lobe predominance. Immunosuppressed patients on methotrexate are at increased risk for NTM infections, which can mimic granulomatous diseases.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a patient on methotrexate with ground-glass opacities, centrilobular nodules, tree-in-bud pattern in upper lobes, and non-necrotizing granulomas. While MAC (C) is defensible given immunosuppression, tree-in-bud pattern, and granulomas, hypersensitivity pneumonitis (E) is equally defensible. HP classically presents with ground-glass opacities, centrilobular nodules, and non-necrotizing granulomas; methotrexate-induced HP is well-documented. The tree-in-bud pattern, while suggestive of infection, can occur in HP. The rationale dismisses HP stating it \\\"usually without tree-in-bud or upper lobe predominance,\\\" but HP can show upper/mid-lobe predominance and tree-in-bud has been reported. The stem lacks critical discriminators: no mention of positive cultures, AFB staining, or specific exposures. Medical accuracy issue: The keyed answer assumes MAC based on pattern alone without microbiological confirmation, which is required for definitive diagnosis. Both MAC and methotrexate-induced HP remain plausible. Minimal fix: Add microbiological data (e.g., \\\"BAL cultures grow MAC\\\") or specify chronic cavitary disease to uniquely support MAC over HP.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a patient on methotrexate with ground-glass opacities, centrilobular nodules, tree-in-bud pattern in upper lobes, and non-necrotizing granulomas. While MAC (C) is defensible given immunosuppression, tree-in-bud pattern, and granulomas, hypersensitivity pneumonitis (E) is equally defensible. HP classically presents with ground-glass opacities, centrilobular nodules, and non-necrotizing granulomas; methotrexate-induced HP is well-documented. The tree-in-bud pattern, while suggestive of infection, can occur in HP. The rationale dismisses HP stating it \"usually without tree-in-bud or upper lobe predominance,\" but HP can show upper/mid-lobe predominance and tree-in-bud has been reported. The stem lacks critical discriminators: no mention of positive cultures, AFB staining, or specific exposures. Medical accuracy issue: The keyed answer assumes MAC based on pattern alone without microbiological confirmation, which is required for definitive diagnosis. Both MAC and methotrexate-induced HP remain plausible. Minimal fix: Add microbiological data (e.g., \"BAL cultures grow MAC\") or specify chronic cavitary disease to uniquely support MAC over HP.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-010", "question": "A 44-year-old woman presents with 8 months of progressive proximal muscle weakness, heliotrope rash, and Gottron's papules. Muscle biopsy shows perfascicular atrophy and MAC deposition on capillaries. She tests positive for anti-MDA5 antibodies. Which of the following complications carries the highest immediate mortality risk?", "options": ["Aspiration pneumonia", "Cardiac conduction abnormalities", "Rapidly progressive interstitial lung disease", "Malignancy-associated deterioration", "Calcinosis universalis"], "answer": "C", "answer_index": 2, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is strongly associated with rapidly progressive interstitial lung disease (RP-ILD), which has mortality exceeding 50% within 6 months despite treatment. This subtype shows characteristic skin findings but often minimal muscle involvement, with MAC deposition on capillaries. While aspiration (A) and cardiac issues (B) occur in myositis, RP-ILD is the most lethal complication in anti-MDA5 patients. Malignancy risk (D) is lower with anti-MDA5 than with anti-TIF1γ. Calcinosis (E) is chronic but not immediately life-threatening. Early recognition and aggressive immunosuppression for RP-ILD are critical in anti-MDA5 dermatomyositis.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 44-year-old woman with classic dermatomyositis features (heliotrope rash, Gottron's papules, proximal weakness) and positive anti-MDA5 antibodies. The muscle biopsy findings (perifascicular atrophy, MAC deposition on capillaries) support dermatomyositis. The key discriminating feature is anti-MDA5 positivity, which is strongly associated with rapidly progressive interstitial lung disease (RP-ILD) carrying mortality rates exceeding 50% within 6 months. This represents the highest immediate mortality risk among the options. Option A (aspiration pneumonia) can occur but is less specific and less immediately lethal. Option B (cardiac conduction abnormalities) occurs in some myositis cases but is not the predominant concern with anti-MDA5. Option D (malignancy) is more associated with anti-TIF1γ antibodies, not anti-MDA5. Option E (calcinosis) is a chronic complication without immediate mortality risk. The stem provides sufficient discriminating information (anti-MDA5 antibody status) to identify RP-ILD as the unique best answer. Medical accuracy is excellent, reflecting current understanding of anti-MDA5-associated dermatomyositis and its life-threatening pulmonary complications. No fix needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 44-year-old woman with classic dermatomyositis features (heliotrope rash, Gottron's papules, proximal weakness) and positive anti-MDA5 antibodies. The muscle biopsy findings (perifascicular atrophy, MAC deposition on capillaries) support dermatomyositis. The key discriminating feature is anti-MDA5 positivity, which is strongly associated with rapidly progressive interstitial lung disease (RP-ILD) carrying mortality rates exceeding 50% within 6 months. This represents the highest immediate mortality risk among the options. Option A (aspiration pneumonia) can occur but is less specific and less immediately lethal. Option B (cardiac conduction abnormalities) occurs in some myositis cases but is not the predominant concern with anti-MDA5. Option D (malignancy) is more associated with anti-TIF1γ antibodies, not anti-MDA5. Option E (calcinosis) is a chronic complication without immediate mortality risk. The stem provides sufficient discriminating information (anti-MDA5 antibody status) to identify RP-ILD as the unique best answer. Medical accuracy is excellent, reflecting current understanding of anti-MDA5-associated dermatomyositis and its life-threatening pulmonary complications. No fix needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]